CMS chief asks Senate to preserve hemp-ban delay for Medicare CBD access

Published Aug 7, 2026

CMS Administrator Mehmet Oz urged senators to reject S. Amendment 6733, which would remove a proposed one-month delay to the Nov. 12 federal hemp restriction, arguing the amendment would disrupt Medicare models that can cover up to $500 annually in qualifying hemp products. Oklahoma hemp operators should watch the vote because Sen. James Lankford is among the amendment’s cosponsors and the outcome affects the federal timetable for full-spectrum CBD products.